Literature DB >> 13120985

Effects of N-methylformamide and related compounds in mouse sarcoma 180.

D A CLARKE, F S PHILIPS, S S STERNBERG, R K BARCLAY, C C STOCK.   

Abstract

Entities:  

Keywords:  FORMATES/effects; URETHANE/effects

Mesh:

Substances:

Year:  1953        PMID: 13120985     DOI: 10.3181/00379727-84-20590

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  12 in total

1.  [Antileukemic effect of N-methylformamide].

Authors:  H BRAUNSTEINER
Journal:  Klin Wochenschr       Date:  1954-07-01

2.  Comparative hepatotoxicity and metabolism of N-methylformamide in rats and mice.

Authors:  K Tulip; J A Timbrell
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

3.  N-Methylformamide in advanced squamous cancer of the uterine cervix: an Eastern Cooperative Oncology Group phase II trial.

Authors:  L Rajdev; Z F Yu; S Wadler; E Weller; S B Kahn; D Tormey; R Skeel; P H Wiernik
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

4.  Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I study.

Authors:  E K Rowinsky; L B Grochow; A Hantel; D S Ettinger; B L Vito; R C Donehower
Journal:  Invest New Drugs       Date:  1989-11       Impact factor: 3.850

5.  N-methylformamide-mediated enhancement of in vitro tumor cell chemosensitivity.

Authors:  P J Tofilon; C M Vines; L Milas
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 6.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

7.  Phase II trial of N-methylformamide in advanced head and neck cancer.

Authors:  W C Vogel; A A Forastiere; R B Natale; B J Takasugi; G Schnur
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

8.  The antitumour effect and toxicity of cis-platinum and N-methylformamide in combination.

Authors:  E S Harpur; S P Langdon; S A Fathalla; J Ishmael
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Enhancement of antitumor activity of the oxazaphosphorine cytostatic SUM-IAP by N-methylformamide.

Authors:  G Voelcker
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-03       Impact factor: 4.553

10.  Viral hepatitis associated with transplantable mouse leukemia. I. Acute hepatic manifestations following treatment with urethane or methylformamide.

Authors:  H BRAUNSTEINER; C FRIEND
Journal:  J Exp Med       Date:  1954-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.